3.1.3 Good Health and Well-being: publications

SDG 3 健康與福祉 THE Impact Rankings 2027 資料年度 2025

Summary

In 2025, China Medical University published 6,507 SDG 3-related papers, as documented in its SciVal data export. Research priorities include targeted cancer therapies and immunotherapy, evidence-based traditional Chinese medicine, precision medicine, cerebrovascular and cardiovascular diseases, and public health. The Office of Research and Development and affiliated hospital teams use Scopus and SciVal to monitor research output across medical and biomedical faculties, research centres, interdisciplinary teams and affiliated hospitals. Internal research funding and incentives for publication in leading journals support interdisciplinary biomedical research and the dissemination of its findings.

說明

本校作為國內頂尖之醫學高教與醫療體系標竿,將健康與福祉(SDG 3)視為核心研究範疇。研發處與附設醫院團隊透過 Elsevier Scopus 資料庫與 SciVal 研發分析工具,定期管考與推動全校於癌症標靶與免疫治療、中醫藥實證醫學、精準醫療、腦心血管疾病及公共衛生等關鍵議題之研究發表規模。

學校訂有完善之研究計畫補助與頂尖期刊獎勵制度,持續挹注資源扶植跨領域生醫團隊投入高影響力論文之產出。

成果

2025 年本校於 Scopus/SciVal 資料庫中,發表於 SDG 3(健康與福祉)範疇之學術論文總篇數達 6,507 篇(如 SciVal 2025 數據導出檔所示),展現本校於全球生醫與健康研究領域強大且持續擴張的學術影響力與論文產出規模。

佐證資料

Elsevier SciVal連結:SDGs - SciVal